Featured Research

from universities, journals, and other organizations

Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates

Date:
August 1, 2013
Source:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Summary:
Hospital-acquired infections' antibiotic resistance is higher than prior CDC reports, and the FDA's reboot of its antibiotic development rules to combat these infections has fallen short.

The rise of antibiotic resistance among hospital-acquired infections is greater than the Centers for Disease Control and Prevention (CDC) found in its 2008 analysis, according to an ahead-of-print article in the journal, Antimicrobial Agents and Chemotherapy.

The article also finds that the Food and Drug Administration's (FDA) promise to "reboot" antibiotic development rules a year ago to combat the rise in resistance has fallen short.

The commentary, whose authors include Brad Spellberg, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) infectious disease specialist, analyzed privately gathered data and concluded antibiotic resistance among hospital-acquired infections is "at crisis levels." The FDA's "reboot" pledge to encourage the development of new antibiotics to battle this resistance "cannot come too soon" but "will not be enough," the authors conclude.

"With antibiotic-resistant microbes infecting more than 2 million Americans every year and killing more than 100,000 annually, we must act to find new weapons in the global battle against deadly Superbugs," said Dr. Spellberg, M.D., who authored "Rising Plague," a book on antibiotic resistance. "Our analysis found the rise in antibiotic resistance among three common forms of hospital-acquired infections is much greater than previously reported by the CDC based on older data, leading us to conclude that more than an FDA 'reboot' is needed. To encourage antibiotic development, the pharmaceutical industry must see that there is a path for a return on its investment in antibiotic development."

The authors found "very positive aspects" in the FDA's most recent guidance for antibacterial therapies for patients with unmet medical needs. But they said the FDA's approach to the development of antibacterials in traditional indications, such as pneumonia and urinary tract infections, "has been mixed."

Their findings on the rise on antibiotic resistance among hospital-acquired infections include:

  • The resistance for acinetobacter (A. baumannii) to carbapenems is more than 50%. The CDC found it to be 11%. Carbapenems are among the last available antibiotics. If they don't work, only one or two other drugs are left to battle these infections. Neither is very effective, and one is highly toxic.
  • The resistance among E. coli to third generation cephalosporins (a class of antibiotics) was 8-11%. The CDC found it to be 5%.
  • The resistance to klebsiella (K. pneumonia) to third generation cephalosporins was 20-27%. The CDC found it to be 15%. Resistance to carbapenems among these isolates is now between 7 and 11%.
  • Carbapenems are already obsolete for a common Intensive Care Unit infection, Acinetobacter baumannii. "This holds true for both intensive care and non-intensive care patients and for urinary and non-urinary infections," the commentary says.

"None of the antibiotics under development today can address all of these antibiotic-resistant infections," said Dr. Spellberg. "A complete overhaul of the approaches to resistance, disease and prevention could change the continuing upward trajectory of antibiotic resistant infections. To do anything less invites a bleak post-antibiotic future, in which infectious diseases once again reign supreme."


Story Source:

The above story is based on materials provided by Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). Note: Materials may be edited for content and length.


Journal Reference:

  1. D. M. Shlaes, D. Sahm, C. Opiela, B. Spellberg. Commentary: The FDA Reboot of Antibiotic Development. Antimicrobial Agents and Chemotherapy, 2013; DOI: 10.1128/AAC.01277-13

Cite This Page:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). "Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates." ScienceDaily. ScienceDaily, 1 August 2013. <www.sciencedaily.com/releases/2013/08/130801113222.htm>.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). (2013, August 1). Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2013/08/130801113222.htm
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). "Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates." ScienceDaily. www.sciencedaily.com/releases/2013/08/130801113222.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins